Two hospitals in the United Kingdom lost millions after the valuation of an artificial intelligence company they invested in dropped and was delisted from London's Stock Exchange for small- and medium-sized growth companies, according to The Register.
The University of Oxford and Oxford University Hospital lost about $11.1 million, and Chelsea and Westminster Hospital NHS Foundation Trust lost around $6.5 million when Sensyne Health's stock prices dropped earlier this year. Both hospitals received company equity in exchange for patient data.
Sensyne Health aimed to develop an artificial technology-driven platform to accelerate new medicine discovery. Several hospitals signed an agreement with Strategic Research Agreements to share millions of deidentified patient health records with the company in exchange for shares.
Both hospitals were given around $6 million worth of equity stake in Sensyne between 2017 and 2018.